Login | DPI Staff queries on depositing or searching to era.daf.qld.gov.au

Ovarian responses in Bos indicus heifers treated to synchronise ovulation with intravaginal progesterone releasing devices, oestradiol benzoate, prostaglandin F2α and equine chorionic gonadotrophin

Share this record

Add to FacebookAdd to LinkedinAdd to XAdd to WechatAdd to Microsoft_teamsAdd to WhatsappAdd to Any

Export this record

View Altmetrics

Butler, S. A. A., Phillips, N. J., Boe-Hansen, G. B., Bo, G. A., Burns, B. M., Dawson, K. and McGowan, M. R. (2011) Ovarian responses in Bos indicus heifers treated to synchronise ovulation with intravaginal progesterone releasing devices, oestradiol benzoate, prostaglandin F2α and equine chorionic gonadotrophin. Animal Reproduction Science, 129 (3-4). pp. 118-126.

Full text not currently attached. Access may be available via the Publisher's website or OpenAccess link.

Article Link: http://doi.org/10.1016/j.anireprosci.2011.11.001

Abstract

The objectives were: (i) improve understanding of the ovarian responses of Bos indicus heifers treated with different ovulation synchronisation protocols, (ii) compare ovarian responses of B. indicus heifers treated with intravaginal progesterone releasing device (IPRD)+oestradiol benzoate (ODB) versus a conventional prostaglandin F2α (PGF2α) protocol and (iii) investigate whether reducing the amount of progesterone (P4) in the IPRD, and treatment with equine chorionic gonadotrophin (eCG) would increase the proportion of heifers with normal ovarian function during the synchronised and return cycles. Two-year-old Brahman (n=30) and Brahman-cross (n=34) heifers were randomly allocated to three IPRD-treatment groups: (i) standard-dose IPRD (Cue-Mate® 1.56g P4; n=17); (ii) half-dose IPRD (Cue-Mate® 0.78g P4; n=15); (iii) half-dose IPRD+300IU eCG at IPRD removal (n=14), and a non-IPRD control group (iv) 2×PGF2α (500μg cloprostenol) on Days -16 and -2 (n=18). IPRD-treated heifers received 250μg cloprostenol at IPRD insertion (Day -10) and IPRD removal (Day -2) and 1mg ODB on Days -10 and -1. Ovarian function was evaluated by ultrasonography and plasma P4 throughout the synchronised and return cycles. The mean diameter of the dominant follicle observed at 54-56h after IPRD removal, was greater for heifers which ovulated than heifers which did not ovulate (P<0.001; 14.5±1.1 vs. 9.3±0.6mm, respectively). The prevalence of IPRD-treated heifers with ovarian dysfunction (persistent CL, failure to re-ovulate, shortened luteal phase) was 39%. This relatively high prevalence of ovarian dysfunction may explain the commonly reported, lower than expected pregnancy rates to FTAI in B. indicus heifers treated to synchronise ovulation. © 2011 Elsevier B.V.

Item Type:Article
Keywords:Bos indicus Fixed-time artificial insemination Ovarian function Ovulation synchronization Progesterone chorionic gonadotropin cloprostenol drug derivative estradiol estradiol 3-benzoate estradiol benzoate prostaglandin F2 alpha seric gonadotropin animal animal disease article artificial insemination blood cattle drug effect estrus cycle female intravaginal drug administration methodology ovary ovulation physiology Administration, Intravaginal Animals Dinoprost Estrus Synchronization Gonadotropins, Equine Insemination, Artificial Equidae
Subjects:Science > Biology > Reproduction
Animal culture > Breeding and breeds
Animal culture > Cattle > Meat production
Live Archive:20 Mar 2019 23:50
Last Modified:03 Sep 2021 16:45

Repository Staff Only: item control page